CA2383877C - Procede de detection de l'expression d'une proteine d'enveloppe d'un retrovirus endogene humain et utilisations d'un gene codant pour cette proteine - Google Patents

Procede de detection de l'expression d'une proteine d'enveloppe d'un retrovirus endogene humain et utilisations d'un gene codant pour cette proteine Download PDF

Info

Publication number
CA2383877C
CA2383877C CA2383877A CA2383877A CA2383877C CA 2383877 C CA2383877 C CA 2383877C CA 2383877 A CA2383877 A CA 2383877A CA 2383877 A CA2383877 A CA 2383877A CA 2383877 C CA2383877 C CA 2383877C
Authority
CA
Canada
Prior art keywords
cells
protein
sequence
envelope
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA2383877A
Other languages
English (en)
French (fr)
Other versions
CA2383877A1 (fr
Inventor
Francois Mallet
Francois-Loic Cosset
Jean-Luc Blond
Dimitri Lavillette
Olivier Bouton
Alessia Ruggieri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomerieux SA
Institut National de la Santé et de la Recherche Médicale
Original Assignee
Biomerieux SA
Institut National de la Santé et de la Recherche Médicale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9911141A external-priority patent/FR2797888A1/fr
Application filed by Biomerieux SA, Institut National de la Santé et de la Recherche Médicale filed Critical Biomerieux SA
Publication of CA2383877A1 publication Critical patent/CA2383877A1/fr
Application granted granted Critical
Publication of CA2383877C publication Critical patent/CA2383877C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA2383877A 1999-09-01 2000-09-01 Procede de detection de l'expression d'une proteine d'enveloppe d'un retrovirus endogene humain et utilisations d'un gene codant pour cette proteine Expired - Lifetime CA2383877C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR9911141A FR2797888A1 (fr) 1999-09-01 1999-09-01 Procede de detection de l'expression d'une proteine d'enveloppe d'un retrovirus endogene humain et utilisations d'un gene codant pour cette proteine
FR99/11141 1999-09-01
FR99/11793 1999-09-15
FR9911793A FR2797889A1 (fr) 1999-09-01 1999-09-15 Procede de detection de l'expression d'une proteine d'enveloppe d'un retrovirus endogene humain et utilisations d'un gene codant pour cette proteine
PCT/FR2000/002429 WO2001016171A1 (fr) 1999-09-01 2000-09-01 Procede de detection de l'expression d'une proteine d'enveloppe d'un retrovirus endogene humain et utilisations d'un gene codant pour cette proteine

Publications (2)

Publication Number Publication Date
CA2383877A1 CA2383877A1 (fr) 2001-03-08
CA2383877C true CA2383877C (fr) 2014-04-15

Family

ID=26235097

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2383877A Expired - Lifetime CA2383877C (fr) 1999-09-01 2000-09-01 Procede de detection de l'expression d'une proteine d'enveloppe d'un retrovirus endogene humain et utilisations d'un gene codant pour cette proteine

Country Status (9)

Country Link
US (1) US7442550B1 (enExample)
EP (2) EP1212359B1 (enExample)
JP (2) JP4283475B2 (enExample)
AT (1) ATE531726T1 (enExample)
AU (1) AU7297100A (enExample)
CA (1) CA2383877C (enExample)
ES (2) ES2376726T3 (enExample)
FR (1) FR2797889A1 (enExample)
WO (1) WO2001016171A1 (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11129892B1 (en) 2020-05-18 2021-09-28 Vnv Newco Inc. Vaccine compositions comprising endogenous Gag polypeptides
US11447527B2 (en) 2018-09-18 2022-09-20 Vnv Newco Inc. Endogenous Gag-based capsids and uses thereof
US12617822B2 (en) 2018-09-18 2026-05-05 Aera Therapeutics, Inc. Arc-based capsids and uses thereof

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002004678A2 (en) * 2000-07-07 2002-01-17 Genetics Institute, Llc. Methods and compositions for diagnosing and treating preeclampsia and gestational trophoblast disorders
EP1651667B1 (en) 2003-04-04 2012-03-28 Centre National De La Recherche Scientifique Protein with fusogenic activity, nucleic acid sequences encoding said protein and pharmaceutical compositions comprising the same
FR2865403B1 (fr) * 2004-01-23 2009-06-12 Biomerieux Sa Composition pour le traitement d'une pathologie associee a la msrv/herv-w
EP2402447A1 (en) 2005-03-30 2012-01-04 Viroxis Endogenous retrovirus and proteins encoded by env gene as a target for cancer treatment
US20100285056A1 (en) * 2008-01-09 2010-11-11 Konkuk University Industrial Cooperation Corp. Baculovirus-Based Vaccines
EP3235828A1 (en) 2016-04-21 2017-10-25 Genethon Stable pseudotyped lentiviral particles and uses thereof
CA3078096A1 (en) 2017-10-20 2018-10-19 Genethon Use of syncytin for targeting drug and gene delivery to regenerating muscle tissue
WO2019077150A1 (en) 2017-10-20 2019-04-25 Genethon USE OF SYNCYTIN TO TARGET A MEDICINAL PRODUCT AND GENE ADMINISTRATION TO PULMONARY TISSUE

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2663040B1 (fr) 1990-06-11 1995-09-15 Bio Merieux Procede de detection d'une sequence nucleotidique selon la technique d'hybridation sandwich.
US6312921B1 (en) * 1996-07-26 2001-11-06 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
WO1999002696A1 (fr) * 1997-07-07 1999-01-21 Bio Merieux Sequences retroviraux endogenes, associees a des maladies auto-immunes et/ou a des perturbations de la grossesse
EP1080106A1 (en) * 1998-05-18 2001-03-07 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11447527B2 (en) 2018-09-18 2022-09-20 Vnv Newco Inc. Endogenous Gag-based capsids and uses thereof
US11505578B2 (en) 2018-09-18 2022-11-22 Vnv Newco Inc. Endogenous Gag-based capsids and uses thereof
US12617822B2 (en) 2018-09-18 2026-05-05 Aera Therapeutics, Inc. Arc-based capsids and uses thereof
US11129892B1 (en) 2020-05-18 2021-09-28 Vnv Newco Inc. Vaccine compositions comprising endogenous Gag polypeptides

Also Published As

Publication number Publication date
ES2444649T3 (es) 2014-02-26
JP2003510032A (ja) 2003-03-18
EP1212359B1 (fr) 2011-11-02
US7442550B1 (en) 2008-10-28
JP4824731B2 (ja) 2011-11-30
ATE531726T1 (de) 2011-11-15
EP2385058A1 (fr) 2011-11-09
JP4283475B2 (ja) 2009-06-24
WO2001016171A1 (fr) 2001-03-08
AU7297100A (en) 2001-03-26
EP1212359A1 (fr) 2002-06-12
CA2383877A1 (fr) 2001-03-08
EP2385058B1 (fr) 2013-11-06
ES2376726T3 (es) 2012-03-16
FR2797889A1 (fr) 2001-03-02
JP2009072194A (ja) 2009-04-09

Similar Documents

Publication Publication Date Title
JP4824731B2 (ja) ヒト内因性レトロウイルスのエンベロープタンパク質の発現を検出する方法、並びに上記タンパク質をコードする遺伝子の使用
Bour et al. The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection
JPH01500879A (ja) Ｔ細胞表面タンパク質ｔ４をコードするｄｎａ並びにｔ４フラグメントのａｉｄｓ治療への使用
EP1651667B1 (en) Protein with fusogenic activity, nucleic acid sequences encoding said protein and pharmaceutical compositions comprising the same
Roebke et al. An N-terminally truncated envelope protein encoded by a human endogenous retrovirus W locus on chromosome Xq22. 3
EP1000158B1 (fr) Sequences retroviraux endogenes, associees a des maladies auto-immunes et/ou a des perturbations de la grossesse
CA2640793C (fr) Domaine peptidique necessaire a l'interaction entre l'enveloppe d'un virus appartenant au groupe d'interference de herv-w et un recepteur hasct
WO2011091716A9 (zh) 表皮生长因子受体变异体
US20020076693A1 (en) Novel cell surface receptor for HIV retroviruses, therapeutic and diagnostic uses
EP1735344B1 (fr) Composition de vaccin comprenant un ligand cmh de classe ii couple a un antigene, procede de preparation et utilisations
US20130115602A1 (en) Endogenetic retroviral sequences, associated with autoimmune diseases or with pregnancy disorders
EP0796338B1 (fr) Lignees cellulaires d'encapsidation pour la transcomplementation de vecteurs retroviraux defectifs
EP1612270B1 (fr) Matérial nucléique retroviral et fragments nucléotidiques, associés à la sclérose en plaques, à des fins de diagnostic, prophylactiques et thérapeutiques
Mummidi et al. Extensive repertoire of membrane-bound and soluble DC-SIGN1 and DC-SIGN2 isoforms: inter-individual variation in expression of DC-SIGN transcripts
US20070203325A1 (en) Integrase-dirived HIV-inhibiting agents
FR2797888A1 (fr) Procede de detection de l'expression d'une proteine d'enveloppe d'un retrovirus endogene humain et utilisations d'un gene codant pour cette proteine
Murcia Late restriction induced by an endogenous retrovirus
Kolokithas Interactions Between the Glycosylated Gag Protein of a Murine Leukemia Virus and Murine Apobec3: Novel Insights Into how a Murine Leukemia Virus Counteracts a Restriction Factor

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20200901